Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Claudia Ana Burillo Vargas

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca
Claudia Ana Burillo Vargas

Claudia Ana Burillo Vargas

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

See more

Related professionals

Anna Sánchez Corral

Anna Sánchez Corral

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Sergio Huertas Torres

Sergio Huertas Torres

Research technician
Transfusional Medicine
Read more
Soraya Micó Milla

Soraya Micó Milla

Read more
Marta Olive Gadea

Marta Olive Gadea

Main researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.